

Retatrutide (RETA)
Triple-agonist research peptide with GIP, GLP-1 and glucagon receptor activity in a single lot-matched vial.
Dosage
$105.00/ 10 mg · USD
| Quantity | Per unit | You save |
|---|---|---|
| 3–4 units | $97.65 | −7% |
| 5–9 units | $93.45 | −11% |
| 10+ units | $88.20 | −16% |
Add 2 more to save 7% on every unit.
The Purity Guarantee
Verified ≥99% by HPLC & mass spectrometry, third-party tested, with a lot-matched Certificate of Analysis on every vial.
- Ships same day on orders placed by 2PM EST
- View this product's Certificate of Analysis
For laboratory and research use only. Not for human or veterinary use.
Triple-agonist research peptide with GIP, GLP-1 and glucagon receptor activity in a single lot-matched vial.
Supplied as part of the GLP-1 & Metabolic line. Material is released only after identity and purity are confirmed for the specific lot being shipped.
Certificate of Analysis & Safety Data
Third-party verified results for every lot we ship. Open, print or save any document instantly — no login required.


